Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FYX-051 vs allopurinol in hyperuricemia (with or without gout)
jRCT2080221074Phase 3
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of topiroxostat in hyperuricemia and gout (2 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.
02
Drugs
topiroxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on jRCT2080221074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221074.